Edge Financial Advisors’s AbbVie ABBV Stock Holding History

Edge Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.55M	Buy	3,397 +25	+0.7%	+$5.7K	0.65%	35
2025 Q3	$1.56M	Buy	3,372 +41	+1%	+$8.35K	0.7%	31
2025 Q2	$620K	Buy	3,331 +75	+2%	+$13.9K	0.33%	55
2025 Q1	$682K	Buy	3,256 +311	+11%	+$60.5K	0.43%	41
2024 Q4	$523K	Buy	2,945 +4	+0.1%	+$735	0.47%	54
2024 Q3	$581K	Buy	2,941 +290	+11%	+$54.1K	0.51%	53
2024 Q2	$455K	Buy	2,651 +113	+4%	+$18.7K	0.47%	52
2024 Q1	$462K	Buy	+2,538	New	+$437K	0.41%	68

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Edge Financial Advisors's ABBV Position: Q4 2025 in Review

Edge Financial Advisors increased its AbbVie (ABBV) stake by 0.74% in Q4 2025, buying an estimated $5.7K and bringing the position to 3,397 shares worth $1.55M. The position accounts for 0.65% of the portfolio, ranked #35.

Edge Financial Advisors first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.56M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Edge Financial Advisors held 3,397 shares of AbbVie worth $1.55M as of Q4 2025.
Edge Financial Advisors bought 25 AbbVie shares in Q4 2025, an estimated $5.7K.
AbbVie made up 0.65% of Edge Financial Advisors's portfolio in Q4 2025, its #35 holding.
Edge Financial Advisors first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
Edge Financial Advisors's AbbVie position peaked at $1.56M in Q3 2025.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Edge Financial Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.